"Concise industry news from the US pharmaceutical industry..."
New Account

The Magazine

Issue 17

Issue 17 E-magazine
  • Previous Issues

Sponsors

Platinum Sponsors
Gold Sponsors
Silver Sponsors
Platinum Sponsors
Gold Sponsors
Silver Sponsors

Blog

Where our team of guest writers discuss what they think about the current NGP US Issues.

Peter Duncan
Director of Business Development

Can digital pathology save drug development?

Peter Duncan of Definiens discusses the potential of digital pathology.
07 Jul 2010
Business Strategies & IT
1 of 4 Previous | Next
Business Strategies & IT

Centralized Patient Recruitment: Effectiveness and Cost Effectiveness


By Acurian. Despite the existence of patient recruitment companies for twenty years or more in the United States, there is a paucity of good data supporting this tactic. However, pharmaceutical companies continue to support both central and local recruitment efforts in an attempt to reduce delays or even speed up critical trials.

No Comments

Drug patent problem rocks AstraZenenca


At the end of last week, the chief executive of AstraZeneca unveiled a 27 percent jump in pre-tax profits for the third quarter. But, with drug patents facing expiration - currently one of the pharmaceutical industry's biggest challenges - just around the corner, it's far from an easy ride for the company.

No Comments

Seeding the Cloud


Trevor Heritage of Symyx Technologies, Inc. discusses the value of hosted informatics in life sciences R&D.

No Comments

The technical side of business


GlaxoSmithKline’s Bill Louv tells Natalie Brandweiner of technology’s role in ensuring successful business solutions, and the responsibility of ensuring the company’s success.

No Comments

Prescription: Technology


NG Pharma speaks with HP’s David Medina to find out how IT can help the life science and pharma industry face some of today’s biggest challenges.

No Comments
1 of 4 Previous | Next